<DOC>
	<DOCNO>NCT01438827</DOCNO>
	<brief_summary>The purpose trial evaluate efficacy two dosing schedule Avanz SQ+ ( Standardised Quality ) Phleum pratense compare placebo subject grass pollen induce allergic rhinoconjunctivitis without asthma .</brief_summary>
	<brief_title>Avanz Phleum Pratense Maintenance Dose</brief_title>
	<detailed_description />
	<mesh_term>Conjunctivitis , Allergic</mesh_term>
	<criteria>A history grass pollen allergy Positive skin prick test grass Positive Immunoglobulin E test grass Other allergy overlap grass pollen season Severe Asthma ( define Forced expiratory volume 1 second ( FEV1 ) 70 % adequate treatment )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>January 2014</verification_date>
</DOC>